Compared with control EVs, treatment of COVID-19 EVs caused a trend toward reduction in the expression of F4/80+CD206+, a marker for M2 macrophage polarization; however, the reduction did not reach statistical significance (Fig. 3C). The gene discussed is MRC1; the disease is COVID-19.